1. Home
  2. VVOS vs CTXR Comparison

VVOS vs CTXR Comparison

Compare VVOS & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • CTXR
  • Stock Information
  • Founded
  • VVOS 2016
  • CTXR 2007
  • Country
  • VVOS United States
  • CTXR United States
  • Employees
  • VVOS N/A
  • CTXR N/A
  • Industry
  • VVOS Medical Specialities
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • VVOS Health Care
  • CTXR Health Care
  • Exchange
  • VVOS Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • VVOS 17.5M
  • CTXR 14.6M
  • IPO Year
  • VVOS 2020
  • CTXR N/A
  • Fundamental
  • Price
  • VVOS $4.43
  • CTXR $2.21
  • Analyst Decision
  • VVOS Strong Buy
  • CTXR Strong Buy
  • Analyst Count
  • VVOS 2
  • CTXR 3
  • Target Price
  • VVOS $6.10
  • CTXR $53.00
  • AVG Volume (30 Days)
  • VVOS 1.7M
  • CTXR 7.2M
  • Earning Date
  • VVOS 08-13-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • VVOS N/A
  • CTXR N/A
  • EPS Growth
  • VVOS N/A
  • CTXR N/A
  • EPS
  • VVOS N/A
  • CTXR N/A
  • Revenue
  • VVOS $14,628,000.00
  • CTXR N/A
  • Revenue This Year
  • VVOS $17.40
  • CTXR N/A
  • Revenue Next Year
  • VVOS $10.78
  • CTXR N/A
  • P/E Ratio
  • VVOS N/A
  • CTXR N/A
  • Revenue Growth
  • VVOS 9.47
  • CTXR N/A
  • 52 Week Low
  • VVOS $1.97
  • CTXR $0.65
  • 52 Week High
  • VVOS $6.28
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 80.66
  • CTXR 79.62
  • Support Level
  • VVOS $3.11
  • CTXR $0.76
  • Resistance Level
  • VVOS $4.68
  • CTXR $1.45
  • Average True Range (ATR)
  • VVOS 0.39
  • CTXR 0.26
  • MACD
  • VVOS 0.19
  • CTXR 0.12
  • Stochastic Oscillator
  • VVOS 90.57
  • CTXR 84.33

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: